GlassScriptPhysician profile
Jonathon J Lebovitz
NPI 1306130885
$12,285.21
in general payments reported to CMS, 2019-2025
32 companies · $2,677 in 2025
The $2,677 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,196 · 2020: $153 · 2021: $710 · 2022: $1,695 · 2023: $3,105 · 2024: $2,750 · 2025: $2,677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,106 · Travel and Lodging: $1,426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,105.91 |
| Travel and Lodging | $1,425.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $2,043.06 | 2021-2024 | |
| Medtronic, INC. | $1,879.91 | 2021-2025 | Pipeline, Spiderfx |
| Depuy Synthes Sales INC. | $1,706.26 | 2019-2025 | Embotrap, Cerebase, N/A |
| Boston Scientific Corporation | $1,125.52 | 2019-2025 | Enroute Transcarotid Stent |
| Penumbra, INC. | $856.49 | 2019-2025 | Penumbra Coil 400, Red 72, Penumbra System |
| Stryker Corporation | $770.64 | 2019-2025 | Axs Vecta 71, Everest Spinal System, Yukon Oct Spinal System |
| Imperative Care, INC | $736.96 | 2023-2025 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm |
| Route 92 Medical, INC. | $714.42 | 2024-2025 | 8f Base Camp Sheath System |
| Microvention, INC. | $426.09 | 2019-2025 | Web Aneurysm Embolization System, Stent, Sofia 6f-131cm Str |
| Globus Medical, INC. | $343.67 | 2019-2025 | Senza, Osteocel, Quartex |
| Nevro Corp. | $339.51 | 2019-2023 | Senza |
| Icotec Medical INC. | $171.55 | 2025 | Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm, Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm |
| Contego Medical, INC | $122.40 | 2025 | |
| Balt USA, LLC | $121.23 | 2022-2023 | Eclipse 2l |
| Silk Road Medical, INC. | $114.59 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $105.74 | 2019-2022 | |
| Cardiva Medical, INC. | $96.18 | 2023-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Nuvasive, INC. | $84.31 | 2019 | |
| Cerapedics INC. | $78.89 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Ossdsign USA Incorporated | $77.29 | 2023 | |
| Djo, LLC | $59.51 | 2024 | Cmf |
| Medtronic USA, INC. | $58.39 | 2019 | |
| Dilon Technologies, INC. | $47.66 | 2025 | Hemoblast Bellows |
| 4web, INC. | $46.98 | 2024 | Spine Truss System |
| Sanara Medtech INC. | $34.57 | 2024 | Celleraterx |
| Microtransponder, INC. | $30.56 | 2025 | |
| Carlsmed, INC. | $25.52 | 2025 | Aprevo |
| Qapel Medical INC | $18.28 | 2025 | |
| Lemaitre Vascular, INC. | $18.01 | 2025 | Anastoclip Gc 8cm (Medium) |
| Cordis US Corp. | $17.82 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.20 | 2024 | Xarelto |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$306,372.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathon Lebovitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.